What tubulin drugs tell us about microtubule structure and dynamics

Seminars in Cell and Developmental Biology

Volumn 22, Issue 9, 2011, Pages 916-926

  Amos, Linda A ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Dynamic instability; FtsZ; Taxol; Tubulin; Vinblastine

Indexed keywords

ALKALOID DERIVATIVE; AMPHETHINILE; BENOMYL; COLCHICINE; COMBRETASTATIN; DOLASTATIN 10; EPOTHILONE DERIVATIVE; GRISEOFULVIN; HALICHONDRIN B; HEMIASTERLIN; MACROLIDE; MAYTANSINE; MICROTUBULE ASSOCIATED PROTEIN; NOCODAZOLE; NOSCAPINE; NUCLEOTIDE; ORYZALIN; PACLITAXEL; PEPTIDE DERIVATIVE; PHENYTOIN; PHOMOPSIN A; PODOPHYLLOTOXIN; RHIZOXIN; ROTENONE; TRIFLURALIN; TUBULIN; TUBULIN MODULATOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

CONFORMATIONAL TRANSITION; DRUG BINDING SITE; DRUG PROTEIN BINDING; MICROTUBULE; MOLECULAR DYNAMICS; MOLECULAR STABILITY; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW;

EID: 82755188164     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.09.014     Document Type: Review

References (124)

1. Kirschner M.W. Implications of treadmilling for the stability and polarity of actin and tubulin polymers in vivo. J Cell Biol 1980, 86:330-334.
2. Mitchison T., Kirschner M. Dynamic instability of microtubule growth. Nature 1984, 312:237-242.
3. Gerdes K., Howard M., Szardenings F. Pushing and pulling in prokaryotic DNA segregation. Cell 2010, 141:927-942.
4. Kueh H.Y., Mitchison T.J. Structural plasticity in actin and tubulin polymer dynamics. Science 2009, 325:960-963.
5. Dumont S., Mitchison T.J. Force and length in the mitotic spindle. Curr Biol 2009, 19:R749-R761.
6. Poulain F.E., Sobel A. The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol Cell Neurosci 2010, 43:15-32.
7. Risinger A.L., Giles F.J., Mooberry S.L. Microtubule dynamics as a target in oncology. Cancer Treat Rev 2009, 35:255-261.
8. Kingston D.G. Tubulin-interactive natural products as anticancer agents. J Nat Prod 2009, 72:507-515.
9. Calligaris D., Verdier-Pinard P., Devred F., Villard C., Braguer D., Lafitte D. Microtubule targeting agents: from biophysics to proteomics. Cell Mol Life Sci 2010, 67:1089-1104.
10. Ravelli R.B., Gigant B., Curmi P.A., Jourdain I., Lachkar S., Sobel A., et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004, 428:198-202.
11. Gigant B., Wang C., Ravelli R.B., Roussi F., Steinmetz M.O., Curmi P.A., et al. Structural basis for the regulation of tubulin by vinblastine. Nature 2005, 435:519-522.
12. Cormier A., Marchand M., Ravelli R.B., Knossow M., Gigant B. Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Rep 2008, 9:1101-1106.
13. Lowe J., Li H., Downing K.H., Nogales E. Refined structure of alpha beta-tubulin at 3.5A resolution. J Mol Biol 2001, 313:1045-1057.
14. Nogales E., Downing K.H., Amos L.A., Lowe J. Tubulin and FtsZ form a distinct family of GTPases. Nat Struct Biol 1998, 5:451-458.
15. Erickson H.P. Atomic structures of tubulin and FtsZ. Trends Cell Biol 1998, 8:133-137.
16. Mukherjee A., Saez C., Lutkenhaus J. Assembly of an FtsZ mutant deficient in GTPase activity has implications for FtsZ assembly and the role of the Z ring in cell division. J Bacteriol 2001, 183:7190-7197.
17. Scheffers D.J., de Wit J.G., den Blaauwen T., Driessen A.J. GTP hydrolysis of cell division protein FtsZ: evidence that the active site is formed by the association of monomers. Biochemistry 2002, 41:521-529.
18. Oliva M.A., Cordell S.C., Lowe J. Structural insights into FtsZ protofilament formation. Nat Struct Mol Biol 2004, 11:1243-1250.
19. Rice L.M., Montabana E.A., Agard D.A. The lattice as allosteric effector: structural studies of alphabeta- and gamma-tubulin clarify the role of GTP in microtubule assembly. Proc Natl Acad Sci U S A 2008, 105:5378-5383.
20. Buey R.M., Diaz J.F., Andreu J.M. The nucleotide switch of tubulin and microtubule assembly: a polymerization-driven structural change. Biochemistry 2006, 45:5933-5938.
21. Oliva M.A., Trambaiolo D., Lowe J. Structural insights into the conformational variability of FtsZ. J Mol Biol 2007, 373:1229-1242.
22. Elie-Caille C., Severin F., Helenius J., Howard J., Muller D.J., Hyman A.A. Straight GDP-tubulin protofilaments form in the presence of taxol. Curr Biol 2007, 17:1765-1770.
23. Chretien D., Fuller S.D., Karsenti E. Structure of growing microtubule ends: two-dimensional sheets close into tubes at variable rates. J Cell Biol 1995, 129:1311-1328.
24. Muller-Reichert T., Chretien D., Severin F., Hyman A.A. Structural changes at microtubule ends accompanying GTP hydrolysis: information from a slowly hydrolyzable analogue of GTP, guanylyl (alpha,beta)methylenediphosphonate. Proc Natl Acad Sci U S A 1998, 95:3661-3666.
25. Wang H.W., Nogales E. Nucleotide-dependent bending flexibility of tubulin regulates microtubule assembly. Nature 2005, 435:911-915.
26. Wang H.W., Long S., Finley K.R., Nogales E. Assembly of GMPCPP-bound tubulin into helical ribbons and tubes and effect of colchicine. Cell Cycle 2005, 4:1157-1160.
27. Erickson H.P., Osawa M. Cell division without FtsZ - a variety of redundant mechanisms. Mol Microbiol 2010, 78:267-270.
28. Rai S.S., Wolff J. Localization of the vinblastine-binding site on beta-tubulin. J Biol Chem 1996, 271:14707-14711.
29. Cormier A., Knossow M., Wang C., Gigant B. The binding of vinca domain agents to tubulin: structural and biochemical studies. Methods Cell Biol 2010, 95:373-390.
30. Leroux P., Fritz R., Debieu D., Albertini C., Lanen C., Bach J., et al. Mechanisms of resistance to fungicides in field strains of Botrytis cinerea. Pest Manag Sci 2002, 58:876-888.
31. Ren Y., Liu W., Jiang H., Jiang Q., Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 2005, 280:34105-34112.
32. Johnson G.E., Parry E.M. Mechanistic investigations of low dose exposures to the genotoxic compounds bisphenol-A and rotenone. Mutat Res 2008, 651:56-63.
33. Hedberg D., Wallin M. Effects of Roundup and glyphosate formulations on intracellular transport, microtubules and actin filaments in Xenopus laevis melanophores. Toxicol In Vitro 2010, 24:795-802.
34. Dorleans A., Gigant B., Ravelli R.B., Mailliet P., Mikol V., Knossow M. Variations in the colchicine-binding domain provide insight into the structural switch of tubulin. Proc Natl Acad Sci U S A 2009, 106:13775-13779.
35. Barbier P., Dorleans A., Devred F., Sanz L., Allegro D., Alfonso C., et al. Stathmin and interfacial microtubule inhibitors recognize a naturally curved conformation of tubulin dimers. J Biol Chem 2010, 285:31672-31681.
36. Xu K., Luduena R.F. Interaction of Nocodazole with tubulin isotypes. Drug Dev Res 2002, 55:39-5291.
37. Zhou J., Panda D., Landen J.W., Wilson L., Joshi H.C. Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint. J Biol Chem 2002, 277:17200-17208.
38. Checchi P.M., Nettles J.H., Zhou J., Snyder J.P., Joshi H.C. Microtubule-interacting drugs for cancer treatment. Trends Pharmacol Sci 2003, 24:361-365.
39. Gupta K., Bishop J., Peck A., Brown J., Wilson L., Panda D. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Biochemistry 2004, 43:6645-6655.
40. Clement M.J, Rathinasamy K., Adjadj E., Toma F., Curmi P.A., Panda D. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin. Biochemistry 2008, 47:13016-13025.
41. McGown A.T., Fox B.W. Interaction of the novel agent amphethinile with tubulin. Br J Cancer 1989, 59:865-868.
42. Smith C.D., Zhang X., Mooberry S.L., Patterson G.M., Moore R.E. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. Cancer Res 1994, 54:3779-3784.
43. Panda D., Singh J.P., Wilson L. Suppression of microtubule dynamics by LY290181. A potential mechanism for its antiproliferative action. J Biol Chem 1997, 272:7681-7687.
44. Lobert S., Ingram J.W., Correia J.J. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly. Cancer Res 1999, 59:4816-4822.
45. Srivastava P., Panda D. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J 2007, 274:4788-4801.
46. Chaudhuri A.R., Luduena R.F. Griseofulvin: a novel interaction with bovine brain tubulin. Biochem Pharmacol 1996, 51:903-909.
47. Amos L.A., Jubb J.S., Henderson R, Vigers G. Arrangement of protofilaments in two forms of tubulin crystal induced by vinblastine. J Mol Biol 1984, 178:711-729.
48. Lin C.M., Hamel E. Effects of inhibitors of tubulin polymerization on GTP hydrolysis. J Biol Chem 1981, 256:9242-9245.
49. Takahashi M., Iwasaki S., Kobayashi H., Okuda S., Murai T., Sato Y. Rhizoxin binding to tubulin at the maytansine-binding site. Biochim Biophys Acta 1987, 926:215-223.
50. Partida-Martinez L.P., Hertweck C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 2005, 437:884-888.
51. Lackner G., Partida-Martinez L.P., Hertweck C. Endofungal bacteria as producers of mycotoxins. Trends Microbiol 2009, 17:570-576.
52. Gupta S., Bhattacharyya B. Antimicrotubular drugs binding to vinca domain of tubulin. Mol Cell Biochem 2003, 253:41-47.
53. Oroudjev E., Lopus M., Wilson L., Audette C., Provenzano C., Erickson H., et al. Maytansinoid-antibody conjugates induce mitotic arrest by suppressing microtubule dynamic instability. Mol Cancer Ther 2010, 9:2700-2713.
54. Mallery D.L., McEwan W.A., Bidgood S.R., Towers G.J., Johnson C.M., James L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A 2010, 107:19985-19990.
55. Kondoh M., Usui T., Nishikiori T., Mayumi T., Osada H. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin. Biochem J 1999, 340:411-416.
56. Usui T., Watanabe H., Nakayama H., Tada Y., Kanoh N., Kondoh M., et al. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin. Chem Biol 2004, 11:799-806.
57. Jordan M.A., Kamath K., Manna T., Okouneva T., Miller H.P., Davis C., et al. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Mol Cancer Ther 2005, 4:1086-1095.
58. Smith J.A., Wilson L., Azarenko O., Zhu X., Lewis B.M., Littlefield B.A., et al. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. Biochemistry 2010, 49:1331-1337.
59. Jimenez-Barbero J., Amat-Guerri F., Snyder J.P. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr Med Chem Anticancer Agents 2002, 2:91-122.
60. Edler M.C, Yang G., Katherine Jung M., Bai R., Bornmann W.G., Hamel E. Demonstration of microtubule-like structures formed with (-)-rhazinilam from purified tubulin outside of cells and a simple tubulin-based assay for evaluation of analog activity. Arch Biochem Biophys 2009, 487:98-104.
61. Kerksie K., Mejillano M.R., Schwartz R.E., Georg G.I., Himes R.H. Interaction of cryptophycin 1 with tubulin and microtubules. FEBS Lett 1995, 377:59-61.
62. Watts N.R., Cheng N., West W., Steven A.C., Sackett D.L. The cryptophycin-tubulin ring structure indicates two points of curvature in the tubulin dimer. Biochemistry 2002, 41:12662-12669.
63. Moores C.A., Milligan R.A. Visualisation of a kinesin-13 motor on microtubule end mimics. J Mol Biol 2008, 377:647-654.
64. Ray A., Okouneva T., Manna T., Miller H.P., Schmid S., Arthaud L., et al. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate. Cancer Res 2007, 67:3767-3776.
65. Bai R., Durso N.A., Sackett D.L., Hamel E. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1. Biochemistry 1999, 38:14302-14310.
66. Nunes M., Kaplan J., Wooters J., Hari M., Minnick A.A.J., May M.K., et al. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin. Biochemistry 2005, 44:6844-6857.
67. Pettit G.R, Srirangam J.K., Barkoczy J., Williams M.D., Boyd M.R., Hamel E., et al. Antineoplastic agents 365. Dolastatin 10 SAR probes. Anticancer Drug Des 1998, 13:243-277.
68. Morejohn L.C., Bureau T.E., Mole-Bajer T., Bajer A.S., Fosket D.E. Oryzalin, a dinitroaniline herbicide, binds to plant tubulin and inhibits microtubule polymerization in vitro. Planta 1987, 172:252-264.
69. Lyons-Abbott S., Sackett D.L., Wloga D., Gaertig J., Morgan R.E., Werbovetz K.A., et al. Alpha-tubulin mutations alter oryzalin affinity and microtubule assembly properties to confer dinitroaniline resistance. Eukaryot Cell 2010, 9:1825-1834.
70. Anthony R.G., Waldin T.R., Ray J.A., Bright S.W., Hussey P.J. Herbicide resistance caused by spontaneous mutation of the cytoskeletal protein tubulin. Nature 1998, 393:260-263.
71. Hall L.C., Rogers J.M., Denison M.S., Johnson M.L. Identification of the herbicide Surflan and its active ingredient oryzalin, a dinitrosulfonamide, as xenoestrogens. Arch Environ Contam Toxicol 2005, 48:201-208.
72. Buey R.M., Barasoain I., Jackson E., Meyer A., Giannakakou P., Paterson I., et al. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem Biol 2005, 12:1269-1279.
73. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971, 93:2325-2327.
74. Li J.Y., Strobel G., Sidhu R., Hess W.M., Ford E.J. Endophytic taxol-producing fungi from bald cypress, Taxodium distichum. Microbiology 1996, 142:2223-2226.
75. Vivero-Escoto J.L., Slowing I.I., Wu C.W., Lin V.S. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 2009, 131:3462-3463.
76. Snyder J.P., Nettles J.H., Cornett B., Downing K.H., Nogales E. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density. Proc Natl Acad Sci U S A 2001, 98:5312-5316.
77. Geney R., Sun L., Pera P., Bernacki R.J., Xia S., Horwitz S.B., et al. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chem Biol 2005, 12:339-348.
78. Yang Y., Alcaraz A.A., Snyder J.P. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY". J Nat Prod 2009, 72:422-429.
79. Sun L., Veith J.M., Pera P., Bernacki R.J., Ojima I. Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel. Bioorg Med Chem 2010, 18:7101-7112.
80. Hari M., Loganzo F., Annable T., Tan X., Musto S., Morilla D.B., et al. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules. Mol Cancer Ther 2006, 5:270-278.
81. Sanchez-Pedregal V.M., Kubicek K., Meiler J., Lyothier I., Paterson I., Carlomagno T. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide. Angew Chem Int Ed Engl 2006, 45:7388-7394.
82. Li H., DeRosier D.J., Nicholson W.V., Nogales E., Downing K.H. Microtubule structure at 8A resolution. Structure 2002, 10:1317-1328.
83. Kar S., Fan J., Smith M.J., Goedert M., Amos L.A. Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J 2003, 22:70-77.
84. Makrides V., Massie M.R., Feinstein S.C., Lew J. Evidence for two distinct binding sites for tau on microtubules. Proc Natl Acad Sci U S A 2004, 101:6746-6751.
85. Samsonov A., Yu J.Z., Rasenick M., Popov S.V. Tau interaction with microtubules in vivo. J Cell Sci 2004, 117:6129-6141.
86. Diaz J.F., Valpuesta J.M., Chacon P., Diakun G., Andreu J.M. Changes in microtubule protofilament number induced by Taxol binding to an easily accessible site. Internal microtubule dynamics. J Biol Chem 1998, 273:33803-33810.
87. Bollag D.M., McQueney P.A., Zhu J., Hensens O., Koupal L., Liesch J., et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 1995, 55:2325-2333.
88. Nettles J.H., Li H., Cornett B., Krahn J.M., Snyder J.P., Downing K.H. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography. Science 2004, 305:866-869.
89. Carlomagno T., Blommers M.J., Meiler J., Jahnke W., Schupp T., Petersen F., et al. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents. Angew Chem Int Ed Engl 2003, 42:2511-2515.
90. Buey R.M., Calvo E., Barasoain I., Pineda O., Edler M.C., Matesanz R., et al. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites. Nat Chem Biol 2007, 3:117-125.
91. Martello L.A., LaMarche M.J., He L., Beauchamp T.J., Smith A.B., Horwitz S.B. The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies. Chem Biol 2001, 8:843-855.
92. Canales A., Matesanz R., Gardner N.M., Andreu J.M., Paterson I., Diaz J.F., et al. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin. Chemistry 2008, 14:7557-7569.
93. Khrapunovich-Baine M., Menon V., Verdier-Pinard P., Smith A.B., Angeletti R.H., Fiser A., et al. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization. Biochemistry 2009, 48:11664-11677.
94. Kar S., Florence G.J., Paterson I., Amos L.A. Discodermolide interferes with the binding of tau protein to microtubules. FEBS Lett 2003, 539:34-36.
95. He L., Orr G.A., Horwitz S.B. Novel molecules that interact with microtubules and have functional activity similar to Taxol. Drug Discov Today 2001, 6:1153-1164.
96. Edler M.C., Buey R.M., Gussio R., Marcus A.I., Vanderwal C.D., Sorensen E.J., et al. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site. Biochemistry 2005, 44:11525-11538.
97. Sato B., Muramatsu H., Miyauchi M., Hori Y., Takase S., Hino M., et al. A new antimitotic substance, FR182877. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo) 2000, 53:123-130.
98. Bai R., Vanderwal C.D., Diaz J.F., Hamel E. Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding. J Nat Prod 2008, 71:370-374.
99. Field J.J., Singh A.J., Kanakkanthara A., Halafihi T., Northcote P.T., Miller J.H. Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. J Med Chem 2009, 52:7328-7332.
100. Miller J.H., Singh A.J., Northcote P.T. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide. Mar Drugs 2010, 8:1059-1079.
101. Pryor D.E., O'Brate A., Bilcer G., Diaz J.F., Wang Y., Wang Y., et al. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 2002, 41:9109-9115.
102. Gaitanos T.N., Buey R.M., Diaz J.F., Northcote P.T., Teesdale-Spittle P., Andreu J.M., et al. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res 2004, 64:5063-5067.
103. Gapud E.J., Bai R., Ghosh A.K., Hamel E. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously. Mol Pharmacol 2004, 66:113-121.
104. Clark E.A., Hills P.M., Davidson B.S., Wender P.A., Mooberry S.L. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol. Mol Pharm 2006, 3:457-467.
105. Hamel E., Day B.W., Miller J.H., Jung M.K., Northcote P.T., Ghosh A.K., et al. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Mol Pharmacol 2006, 70:1555-1564.
106. Huzil J.T., Chik J.K., Slysz G.W., Freedman H., Tuszynski J., Taylor R.E., et al. A unique mode of microtubule stabilization induced by peloruside A. J Mol Biol 2008, 378:1016-1030.
107. Nguyen T.L., Xu X., Gussio R., Ghosh A.K., Hamel E. The assembly-inducing laulimalide/peloruside A binding site on tubulin: molecular modeling and biochemical studies with [(3)H]peloruside A. J Chem Inf Model 2010, 50:2019-2028.
108. Bennett M.J., Barakat K., Huzil J.T., Tuszynski J., Schriemer D.C. Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping. Chem Biol 2010, 17:725-734.
109. Inatsuki S., Noguchi T., Miyachi H., Oda S., Iguchi T., Kizaki M., et al. Tubulin-polymerization inhibitors derived from thalidomide. Bioorg Med Chem Lett 2005, 15:321-325.
110. Li P.K., Pandit B., Sackett D.L., Hu Z., Zink J., Zhi J., et al. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities. Mol Cancer Ther 2006, 5:450-456.
111. Hashimoto Y. Thalidomide as a multi-template for development of biologically active compounds. Arch Pharm (Weinheim) 2008, 341:536-547.
112. Fourniol F.J., Sindelar C.V., Amigues B., Clare D.K., Thomas G., Perderiset M., et al. Template-free 13-protofilament microtubule-MAP assembly visualized at 8 A resolution. J Cell Biol 2010, 19:463-470.
113. Vitre B., Coquelle F.M., Heichette C., Garnier C., Chretien D., Arnal I. EB1 regulates microtubule dynamics and tubulin sheet closure in vitro. Nat Cell Biol 2008, 10:415-421.
114. des Georges A., Katsuki M., Drummond D.R., Osei M., Cross R.A., Amos L.A. Mal3, the Schizosaccharomyces pombe homolog of EB1, changes the microtubule lattice. Nat Struct Mol Biol 2008, 15:1102-1108.
115. Hyman A.A., Chretien D., Arnal I., Wade R.H. Structural changes accompanying GTP hydrolysis in microtubules: information from a slowly hydrolyzable analogue guanylyl-(alpha,beta)-methylene-diphosphonate. J Cell Biol 1995, 128:117-125.
116. Aylett C.H.S., Wang Q., Michie K.A., Amos L.A., Lowe J. Filament structure of bacterial tubulin homologue TubZ. Proc Natl Acad Sci U S A 2010, 107:19766-19771.
117. O'Toole E.T., McDonald K.L., Mantler J., McIntosh J.R., Hyman A.A., Muller-Reichert T. Morphologically distinct microtubule ends in the mitotic centrosome of Caenorhabditis elegans. J Cell Biol 2003, 163:451-456.
118. Hoog J.L., Schwartz C., Noon A.T., O'Toole E.T., Mastronarde D.N., McIntosh J.R., et al. Organization of interphase microtubules in fission yeast analyzed by electron tomography. Dev Cell 2007, 12:349-361.
119. Kukulski W., Schorb M., Welsch S., Picco A., Kaksonen M., Briggs J.A. Correlated fluorescence and 3D electron microscopy with high sensitivity and spatial precision. J Cell Biol 2011, 192:111-119.
120. Bieling P., Laan L., Schek H., Munteanu E.L., Sandblad L., Dogterom M., et al. Reconstitution of a microtubule plus-end tracking system in vitro. Nature 2007, 450:1100-1105.
121. Katsuki M., Drummond D.R., Osei M., Cross R.A. Mal3 masks catastrophe events in Schizosaccharomyces pombe microtubules by inhibiting shrinkage and promoting rescue. J Biol Chem 2009, 284:29246-29250.
122. Zanic M., Stear J.H., Hyman A.A., Howard J. EB1 recognizes the nucleotide state of tubulin in the microtubule lattice. PLoS ONE 2009, 4:e7585.
123. Sui H., Downing K.H. Structural basis of interprotofilament interaction and lateral deformation of microtubules. Structure 2010, 18:1022-1031.
124. Kikkawa M. The role of microtubules in processive kinesin movement. Trends Cell Biol 2008, 18:128-135.